Md. Coleman et al., Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds: II, ENV TOX PH, 8(3), 2000, pp. 167-172
The in vitro toxicity of two amidrazones I [N-1-(3-benzyloxy-4-methoxybenzy
lidene)-pyridine-2-carboamidrazone] and II [N-1-(4-benzyloxy-3-methoxybenzy
lidene)-yridine-2-carboxamidrazone] and their precursors PI (3-benzyloxy-4-
methoxybenzaldehyde) and PII (4-benzyloxy-3-methoxybenzaldehyde) was determ
ined using a rat liver metabolism system with human mononuclear leucocytes
(MNL) as target cells. The minimum inhibitory concentration for I and II wa
s determined to be between 4 and 8 mu g/ml against Mycobacteria fortuitum.
In direct contact with human MNL at three concentrations, only II and isoni
azid (INH) were significantly more toxic compared with control at 100 and 2
00 mu M. With rat microsomes, INH and PII at 50 mu M showed significant tox
icity. In the two compartment system without a metabolising system, INH and
II were significantly more toxic compared with control and I. In the prese
nce of the metabolising system, INH and PI were more toxic than control and
INH was more toxic compared with I. II was not significantly more toxic th
an control. INH caused more cell death in the presence of the metabolising
system compared with its absence. Less toxic compared with INH, compound I
has shown promise for future development as an antituberculosis drug. (C) 2
000 Elsevier Science B.V. All rights reserved.